
    
      All subjects who completed 1-year follow-up of the LAmbreTM LAA system registration trial
      will be conducted 2 years, 3 years, 4 years and 5 years follow-up by the telephone call.

      During the follow-up, the investigator or his/her designee will use a standardized form to
      record the occurrence of the subject's safety events and validity endpoint by telephoneï¼Œand
      complete the safety and efficacy summary report. The endpoints of the study included compound
      events, MACCE events, stroke, haemorrhage and other events.
    
  